- $4.04m
- $4.90m
- $1.59m
- 49
- 33
- 82
- 55
Annual balance sheet for Vycor Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.046 | 0.091 | 0.037 | 0.057 | 0.106 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.159 | 0.126 | 0.156 | 0.215 | 0.245 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.464 | 0.487 | 0.518 | 0.584 | 0.696 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.505 | 0.442 | 0.336 | 0.402 | 0.296 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.987 | 0.935 | 0.86 | 0.992 | 0.998 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.74 | 3.15 | 3.65 | 4.07 | 4.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.97 | 3.33 | 3.8 | 4.32 | 4.69 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -1.98 | -2.4 | -2.94 | -3.33 | -3.69 |
Total Liabilities & Shareholders' Equity | 0.987 | 0.935 | 0.86 | 0.992 | 0.998 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |